Article metrics

Download PDFPDF
Lack in Efficacy for Imatinib Mesylate as Second-Line Treatment of Recurrent or Metastatic Cervical Cancer Expressing Platelet-Derived Growth Factor Receptor α

 

Online download statistics by month:

Online download statistics by month: March 2019 to June 2021

AbstractFullPdf
Mar 20191400
Apr 20191600
May 20193100
Jun 20192301
Jul 20192600
Aug 20192100
Sep 20191701
Oct 20191000
Nov 2019603
Dec 20191400
Jan 20201600
Feb 20202700
Mar 20203400
Apr 20201103
May 20202100
Jun 20204500
Jul 20201000
Aug 20201400
Sep 20201400
Oct 20201300
Nov 20201700
Dec 20201200
Jan 20212000
Feb 2021600
Mar 20211800
Apr 2021800
May 2021300
Jun 2021100
Total46808